Showing results (21-30 of 67) with videos related to
Sort By:
Pageof 7
Veterinary Microbiology|June 5, 2016
Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccineMariette F Ducatez, Jens Becker, Astrid Freudenstein, et al.Journal of Virology|January 29, 2011
N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infectionMeike S Gratz, Yasemin Suezer, Melanie Kremer, et al.Plos Pathogens|March 8, 2012
Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpoxMelanie Kremer, Yasemin Suezer, Asisa Volz, et al.The Journal of General Virology|September 1, 2025
Robust polyfunctional CD8+ and CD4+ T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoproteinAlina Tscherne, Georgia Kalodimou, Sylvia Jany, et al.Frontiers in Veterinary Science|April 7, 2025
Evaluating the potential of anti-dsRNA antibodies as an alternative viral sensing tool in encephalitides of different speciesMadeleine de le Roi, Hannah Gerhards, Adnan Fayyad, et al.Vaccines|January 8, 2025
Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in HumansAlina Tscherne, Georgia Kalodimou, Alexandra Kupke, et al.BMC Veterinary Research|June 13, 2026
Exploration of the relationship between laboratory stress parameters and leukocyte coping capacity in ponies exposed to repetitive handling during a research projectPhebe De Heus, Jessica Maute, Nikolaus Huber, et al.Journal of Virology|May 29, 2015
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike GlycoproteinAsisa Volz, Alexandra Kupke, Fei Song, et al.Viruses|July 19, 2014
Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesArwen F Altenburg, Joost H C M Kreijtz, Rory D de Vries, et al.NPJ Vaccines|October 17, 2018
Generation of therapeutic antisera for emerging viral infectionsRebecca Schmidt, Lea C Beltzig, Bevan Sawatsky, et al.Pageof 7